Earnings Feed
Start Free
Oruka Therapeutics, Inc.·4

Mar 17, 4:08 PM ET

Sandler Laura Lee 4

Research Summary

AI-generated summary

Updated

Oruka Therapeutics (ORKA) COO Laura Lee Sandler Sells 600 Shares

What Happened
Laura Lee Sandler, Chief Operating Officer of Oruka Therapeutics (ORKA), sold 600 shares on 2026-03-16 at $41.30 per share, generating $24,780 in proceeds. The transaction is a sale (code S) and was reported on a Form 4 filed 2026-03-17.

Key Details

  • Transaction date and price: 2026-03-16 — 600 shares sold at $41.30 each.
  • Total proceeds: $24,780.
  • Shares owned after transaction: Not specified in the filing.
  • Footnote: The sale was effected pursuant to Oruka’s automatic, non-discretionary sell-to-cover procedure to satisfy tax withholding arising from the vesting of restricted stock units (RSUs).
  • Filing timeliness: Form 4 was filed on 2026-03-17 (one day after the transaction), which is within the normal reporting window.

Context
Sell-to-cover transactions are routine tax-withholding sales tied to RSU vesting and do not necessarily indicate a personal view on the company’s prospects. For retail investors, purchases are typically a stronger signal than these kinds of withholding sales.